Solventum Corporation
SOLV
Rang in aandelen
#1483
Solventum Corporation, established in 2023 and headquartered in Saint Paul,... Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
Aandeelprijs
$86.20
Marktkapitalisatie
$14.67B
Verandering (1 dag)
-0.24%
Verandering (1 jaar)
18.23%
Land
US
Handel Solventum Corporation (SOLV)
Categorie
Healthcare
Aandelsplitsingen voor Solventum Corporation (SOLV)
Het aandeel Solventum Corporation (symbool: SOLV) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Oct 21, 2026.
Eén aandeel SOLV dat vóór Oct 21, 2026 werd gekocht, staat nu gelijk aan 0 aandelen SOLV.
De meest recente splitsing vond plaats op Oct 21, 2026.
Eén aandeel SOLV dat vóór Oct 21, 2026 werd gekocht, staat nu gelijk aan 0 aandelen SOLV.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| Niet genoeg gegevens voor de verstrekte datums. | |||
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 3 | x4 |
US
|
|
| 3 | x20 |
FR
|
|
| 0 | - |
JP
|
|
| 6 | x20 |
US
|
|
| 0 | - |
CH
|
